Leuthold Group’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
FMI
DSA
Leuthold Group's DGX Position: Q4 2021 in Review
Leuthold Group sold out of Quest Diagnostics (DGX) in Q4 2021, closing a stake of 20,410 shares — an estimated $2.97M sold.
Leuthold Group first reported a position in DGX in Q2 2013 and held it in 18 quarters. The position peaked at $6.94M in Q2 2018. 905 funds tracked by Wall St. Rank hold DGX as of Q4 2021.
- Leuthold Group reported no remaining Quest Diagnostics position as of Q4 2021 after selling out during the quarter.
- Leuthold Group sold 20,410 Quest Diagnostics shares in Q4 2021, an estimated $2.97M.
- Leuthold Group first reported a position in Quest Diagnostics in Q2 2013 and held it in 18 quarters.
- Leuthold Group's Quest Diagnostics position peaked at $6.94M in Q2 2018.
- 905 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2021.
Based on Leuthold Group's 13F filing for Q4 2021, filed 3 Feb 2022.